Research shows that babies born to mothers who took the fertility drug Clomid during pregnancy are more likely to develop serious birth defects.
Clomid (generic: clomiphene) is a fertility drug used to stimulate the release of hormones needed for a woman’s ovulation to occur. The FDA approved Clomid in 1967 for the treatment of major depression. Studies have linked Clomid to many serious and life-threatening congenital defects, such as:
- Spina Bifida – nearly 12 times increased risk
- Cloacal Exstrophy – more than 5 times increased risk
- Ventricular Septal Defect (heart defect) – nearly 5 times increased risk
- Atrial Septal Defect (heart defect) – 60 percent increased risk
- Dandy-Walker Syndrome (neural tube defect)– 4.4 times increased risk
- Anencephaly (fatal neural tube defect) – 2.3 times increased risk
- Esophageal Atresia (defect of the esophagus) – 2.3 times increased risk
- Craniosynostosis (cranio facial defect) – nearly doubled risk
- Omphalocele – doubled risk
- Anotia/Microtia (defects of the ear) – more than doubled risk
- Intestinal Atresia (defect of the intestines) – 40 percent more likely
- Coarctation of the Aorta – 80 percent increased risk
- Hypospadias (defect of the male genitals) – 50 percent increased risk
- Autism Spectrum Disorders
Extensive Research Links Clomid to Defects
The Center for Disease Control and Prevention’s National Birth Defects Study has linked the use of Clomid two months before to one month after conception to many serious birth defects, including those listed above.
Research conducted by Wu et al. at the University of California, San Francisco found that maternal use of Clomid within 60 days before or 15 days after conception may increase the likelihood of a baby developing spina bifida by nearly 12 times.
A study conducted by the Harvard School of Public Health found that maternal use of Clomid is a risk factor for autism spectrum disorders.
Your Baby’s Rights
If your baby was born with one or more congenital defects that may have been caused by exposure to Clomid before birth, your family deserves financial compensation. No amount of money can change what happened to your baby. Compensation will help offset the current and future medical costs, as well as provide for the pain and suffering you and your baby have experienced.
Filing a claim will also teach the manufacturers of unsafe medications that it is unacceptable to not warn parents of the risks associated with these drugs. This includes serious birth defects. Your suit may also even prevent other families from suffering as yours has. This will force the pharmaceutical company to change their drug’s label to warn parents of the potential risks.
You may be eligible for compensation to ease the financial burdens associated with your baby’s injury. Contact us today to set up a free consultation, during which we will listen to your story, answer any questions you may have and discuss your legal rights and options. If you choose us to represent you, we will work with you on a contingency fee basis; this means you pay nothing until we have secured compensation for you, either through a jury verdict or settlement.
The Michael Brady Lynch Firm is dedicated to obtaining justice on behalf of the babies and their parents who have been harmed by huge pharmaceutical corporations. Principal lawyer Michael Brady Lynch was born with a congenital heart defect that required extensive surgery to correct. He knows how it feels to bear the burden of a lifelong scar. Also, how to live with the painful memories. He is passionate about helping infants and families who have dealt with similar circumstances.
The experienced trial attorneys of The Michael Brady Lynch Firm skillfully and tenaciously fight for the maximum compensation. We will also provide full support to your family every step of the way. Our firm has access to the medical experts and resources necessary to build a powerful claim on each client’s behalf. As true consumer advocates, we are determined to make a difference in the lives of our clients and for the safety of our community.